VistaGen Therapeutics | 8-K:重大事件
04/26 13:57 (美东)
VistaGen Therapeutics | DEF 14A:股东委托书决议
04/16 06:05 (美东)
VistaGen Therapeutics | PRE 14A:并购重组委托声明
04/05 17:34 (美东)
VistaGen Therapeutics | 8-K:重大事件
04/01 17:29 (美东)
VistaGen Therapeutics | 4:持股变动声明-董事 Rotunno Mary L.
03/06 18:05 (美东)
VistaGen Therapeutics | 4:持股变动声明-董事 GIN JERRY B
03/06 18:05 (美东)
VistaGen Therapeutics | 4:持股变动声明-董事 FitzPatrick Margaret M
03/06 18:05 (美东)
VistaGen Therapeutics | 4:持股变动声明-董事 Curley Joanne
03/06 18:05 (美东)
VistaGen Therapeutics | 4:持股变动声明-董事 Cunningham Ann Michelle
03/06 18:05 (美东)
VistaGen Therapeutics | 4:持股变动声明-董事 SAXE JON S
03/06 18:05 (美东)
VistaGen Therapeutics | EFFECT:其他
03/01 06:09 (美东)
VistaGen Therapeutics | CORRESP:信函
02/27 13:40 (美东)
VistaGen Therapeutics | UPLOAD:其他
02/16 13:40 (美东)
VistaGen Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Kenneth Griffin(5.8%),Citadel Advisors LLC(5.6%)等
02/14 18:23 (美东)
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%)等
02/14 16:58 (美东)
VistaGen Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%)等
02/14 16:46 (美东)
VistaGen Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(3.0%),Point72 Capital Advisors, Inc.(3.0%)等
02/14 08:57 (美东)
VistaGen Therapeutics | SC 13G:超过5%持股股东披露文件-The Vanguard Group(6.79%)
02/13 22:30 (美东)
VistaGen Therapeutics | S-3:特定交易注册声明
02/13 16:57 (美东)
VistaGen Therapeutics | 8-K:Vistagen公布2024财年第三季度财务业绩并提供公司最新情况
02/13 16:35 (美东)
暂无数据
暂无数据